• ACE抑制剂血管紧张受体拮抗剂合用吗?

    Should ACE Inhibitors be Combined with Angiotensin II Receptor Antagonists?

    youdao

  • 内皮受体拮抗剂已知健康有益具体机制不明确

    Endothelin receptor antagonists are known to have health benefit but precisely why was an unknown, said Pollock, corresponding author on the study.

    youdao

  • 内皮受体拮抗剂波生坦治疗肺动脉高压有效药物之一

    The endothelin receptor antagonist bosentan is one of the effective drugs for pulmonary arterial hypertension.

    youdao

  • 丙谷胺60年代创制治疗消化性溃疡受体拮抗剂

    Proglumide is a gastrin receptor antagonist synthesized in the middle of 1960s which can be used in the treatment of peptic ulcer.

    youdao

  • 我们评价卒中早期应用血管紧张素受体拮抗剂替米沙坦作用

    We evaluated the effects of therapy with an angiotensin-receptor blocker, telmisartan, initiated early after a stroke.

    youdao

  • 对于患者人群这种血管紧张受体拮抗剂发挥了前所未有的血压控制作用。

    The angiotensin receptor blocker also yielded unprecedented blood pressure control for this population of patients.

    youdao

  • 前言:目的:观察血管紧张受体拮抗剂沙坦对肾病综合征干预保护作用

    Objective: to observe the role of Angiotensin II receptor antagonist valsartan on kidney of rat with nephrotic syndrome.

    youdao

  • 血管紧张转化抑制剂血管紧张受体拮抗剂联合用药治疗CKD是否应用要好?

    Is Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Combination therapy Better Than Monotherapy and Safe in Patients With CKD?

    youdao

  • 结论内皮受体拮抗剂BQ - 123对缺血性急性肾功能衰竭早期肾脏具有一定保护作用

    Conclusion the endothelin receptor antagonist BQ 123 does provide a certain degree of protection for kidneys from the early stage of IARF.

    youdao

  • 目的探讨血管紧张受体拮抗剂缬沙坦对链佐菌诱导的糖尿病大鼠代谢氧化应激胰腺病理结构影响

    Objective to assess the effects of valsartan (an angiotensin receptor blocker, ARB) on glucose metabolism, oxidative stress and pancreatic pathology in streptozotocin-induced diabetic rats.

    youdao

  • 发明提供具有高血糖受体拮抗剂活性反向激动剂活性新颖i化合物及其药学上可接受晶体。

    The present invention provides for novel compounds of Formula (I) and pharmaceutically acceptable salts and co-crystals thereof which have glucagon receptor antagonist or inverse agonist activity.

    youdao

  • 目的研究血管紧张转换抑制剂(acei)血管紧张受体拮抗剂(arb)2糖尿病肾病患者肾功能保护作用

    Objective to investigate the protective effect of angiotensin converting enzyme inhibitor (ACEI) and angiotensin receptor antagonist (ARB) on renal function of type 2 diabetic nephropathy patients.

    youdao

  • 瑞士最大生物科技公司Actelion股价下跌8.6%,此前公司生产内皮素受体拮抗剂克拉生坦没有达到研发的主要目标

    Actelion Ltd., the largest Swiss biotechnology company, sank 8.6 percent after its clazosentan medicine didn’t meet the main goal of a study.

    youdao

  • 我们比较血管紧张转换酶抑制剂雷米普利、血管紧张素受体拮抗剂替米沙坦以及联合血管性疾病高位糖尿病患者的作用。

    We compared the ACE inhibitor ramipril, the ARB telmisartan, and the combination of the two drugs in patients with vascular disease or high-risk diabetes.

    youdao

  • 西他生坦服用者中出现不可逆转肝功能衰竭及其全球市场的召回事件,强调服用内皮受体拮抗剂患者进行肝功能监测重要性

    The irreversible liver failure caused by sitaxsentan and its withdrawal from global markets emphasise the importance of hepatic monitoring in patients treated with endothelin receptor antagonists.

    youdao

  • 虽然剂量血管紧张II注射对雄性小鼠血压没有影响但却显著减低雌鼠平均动脉压,而现象能够血管紧张素受体拮抗剂PD123319所阻断。

    Although this low dose had no effect on MAP in the male, it significantly decreased MAP in the female, and this effect was prevented by coinfusing the animals with PD123319, an antagonist of the AT2R.

    youdao

  • 如果这些结果将来研究证实,那么血管加压v 2受体拮抗剂可能将成为新的降压策略尤其是适用黑人种群

    If these results are confirmed in further studies, then vasopressin V2 receptor antagonists might offer a novel antihypertensive strategy, especially in the black population.

    youdao

  • 研究旨在评价血管加压v 2受体拮抗剂急性血流动力学效应

    This study sought to assess the acute hemodynamic effect of vasopressin V2 receptor antagonism.

    youdao

  • 束旁核内注入胆囊收缩-A受体拮抗剂L-364,718翻转八肽胆囊收缩对抗电针镇痛作用

    The injection of cholecystokinin-A receptor antagonist L-364,718 in parafascicularis nucleus could reverse the antagonism of cholecystokinin octapeptide to the effect of electroacupuncture.

    youdao

  • 结论增强BGC-823细胞系运动,有促进肿瘤细胞转移作用,受体拮抗剂抑制胃泌的这种作用。

    Conclusion Gastrin can aggravate the motion and metastasis of BGC 823 cells, which can be inhibited by its receptor antagonist.

    youdao

  • 但是对轻中度收缩性HF患者,螺内酯联合血管紧张ii受体拮抗剂室(LV)重构价值目前不清楚。

    However, the value of combining spironolactone with an angiotensin II receptor blocker on LV reverse remodeling in mild-to-moderate systolic HF is unclear.

    youdao

  • 拮抗剂肾上腺素受体阻滞剂ACEI类一直位居位。

    Calcium antagonists, adrenoceptor blockers and ACEI were holding first three places.

    youdao

  • 目的观察白细胞6受体拮抗剂外伤性脊髓水肿影响探讨白细胞介6外伤性脊髓水肿中的作用

    OBJECTIVE: To observe the effect of the receptor antagonist of the IL-6 on the traumatic edema of spinal cord, and explore the effect of IL-6 in the process of the edema of spinal cord.

    youdao

  • 目前已知一类称为内皮受体A拮抗剂药物减少蛋白尿

    It's also known that a new class of drugs called endothelin a receptor antagonists reduce protein in the urine.

    youdao

  • 白细胞介6受体拮抗剂治疗细胞水肿变性坏死创伤组轻。

    The cellular edema, degeneration and the necrosis in the receptor antagonist of the IL-6 treated group was milder than that in the wound group.

    youdao

  • 结果在用阿仑单抗治疗白细胞-2受体拮抗剂治疗患者中的活组织检查出肾小球疾病复发率相似

    RESULTS. : Biopsy-proven glomerular disease recurrence was similar in patients induced with alemtuzumab or IL-2 receptor antagonists.

    youdao

  • 目的研究不同剂量内皮受体A拮抗剂FR139317大鼠心力衰竭模型的作用。

    AIM: To study the effects of a selective endothelin receptor A (ETA) antagonist FR139317 on rats with congestive heart failure.

    youdao

  • 抗高血压新药非肽类血管紧张ii受体拮抗剂二十世纪八十年代发现以来就受到了广泛的关注。

    Antihypertensive non-peptide angiotensin II receptor antagonists have been paid much attention since it was found in 1980's.

    youdao

  • 第三致力于吲唑脲类辣椒受体TRPV1)通道拮抗剂定量构效关系QSAR研究

    The third chapter was devoted to the study of quantitative structure-activity relationship(QSAR) for indazolyl ureas as TRPV1 antagonists.

    youdao

  • 结果拮抗剂肾上腺受体阻滞、血管紧张转化酶抑制剂(acei)用药金额、用药频度上分别占前三位

    Results the amount used DDDs of calcium antagonists, adrenergic receptor blockers and ACEI drugs were the head of three.

    youdao

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定